Revolutionizing Pathology with AI
Our vision: Supporting Research, Clinical Practice, and Data Integration
Our vision extends beyond the clinical diagnosis. We are committed to facilitating seamless integration of research, clinical practice, and comprehensive data management. By bridging these domains, aetherAI enables a ecosystem where data research, advances clinical practice, and clinical outcomes.
Core Mission: AI-Enhanced Pathology Analysis
At aetherAI, our core value lies in leveraging artificial intelligence to fundamentally improve pathology analysis. We believe AI is the key to unlocking new levels of accuracy, efficiency, and insights in pathology, transforming patient diagnosis and treatment.
Empowering Pathology, Enabling Precision
We specialize in pathology AI applications and workflow integration to advance digital pathology. Our focus includes disease classification, lesion detection, and differential cell counting, particularly in hematopathology. With over 20 AI projects worldwide, we support hospitals and pharma with AI-enhanced diagnostics and research, targeting precision medicine. Our solution integrates seamlessly with clinical systems, leveraging AI for a streamlined diagnostic workflow.
Our Solutions: Digital Pathology Pioneered
aetherAI offers a comprehensive suite of digital pathology solutions:
aetherSlide
A cutting-edge digital pathology platform that combines slide scanning, image management, and AI-driven analysis to streamline pathology workflows. It enables pathologists to swiftly access, share, and examine slides with accuracy.
aetherAI Hema
Tailored for hematopathology, this AI application automates bone marrow smear cell location, classification and quantification. It significantly cuts down interpretation time, reduces manual labor, and supplies objective, traceable, and reliable data for diagnostic decisions.
Enhanced Pathology with aetherAI’s True GigaPixel AI
True GigaPixel AI leverages a deep neural network to enhance pathology image analysis, capable of processing ultra-high resolution pathology images, enhancing detection of metastasis and streamlining lymph node assessments. It boosts diagnostic sensitivity for micrometastases and reduces review times, significantly improving efficiency and accuracy for pathologists.
Our Approach: Collaborative Innovation and Success Stories:
Europe’s Pioneer:
Partnership with University Hospital Tübingen has been integral to the hospital’s digital transformation, effectively upgrading the pathology department’s capabilities across 5 departments and 3 campuses
Development of AI applications that significantly increase concordance between AI analysis and pathologist diagnoses for breast and gastric cancer, streamlining diagnostic processes and enhancing accuracy
Taiwan’s Benchmark:
Chang Gung Memorial Hospital, Taiwan’s largest private hospital group, embraced aetherSlide since May 2020
The adoption of our system has led to remarkable improvements in work efficiency and diagnostic precision, reducing review times and optimizing decision-making in team meetings
Integration of advanced AI applications empowers pathologists with tools for more accurate and faster diagnoses
Japan’s Milestone:
First implementation of aetherSlide in japan at National Cancer Center Hospital East.
Supports comprehensive research and advances in cancer diagnostics.
AI applications improve lymph node metastasis detection and biomarker quantification, leading to more personalized treatments.
